Matsuoka M, Narita M, Okazaki N, Ohya H, Yamazaki T, Ouchi K, et al. Characterization and molecular analysis of macrolide-resistant Mycoplasma pneumoniae clinical isolates obtained in Japan. Antimicrob Agents Chemother. 2004;48:4624–30.
Article
CAS
PubMed
PubMed Central
Google Scholar
Atkinson TP, Balish MF, Waites KB. Epidemiology, clinical manifestations, pathogenesis and laboratory detection of Mycoplasma pneumoniae infections. FEMS Microbiol Rev. 2008;32:956–73.
Article
CAS
PubMed
Google Scholar
Eun BW, Kim NH, Choi EH, Lee HJ. Mycoplasma pneumoniae in Korean children: the epidemiology of pneumonia over an 18-year period. J Inf Secur. 2008;56:326–31.
Google Scholar
Hong KB, Choi EH, Lee HJ, Lee SY, Cho EY, Choi JH, et al. Macrolide resistance of Mycoplasma pneumoniae, South Korea, 2000-2011. Emerg Infect Dis. 2013;19:1281–4.
Article
PubMed
PubMed Central
Google Scholar
Kim NH, Lee JA, Eun BW, Shin SH, Chung EH, Park KW, et al. Comparison of polymerase chain reaction and the indirect particle agglutination antibody test for the diagnosis of Mycoplasma pneumoniae pneumonia in children during two outbreaks. Pediatr Infect Dis J. 2007;26:897–903.
Article
PubMed
Google Scholar
Miyashita N, Kawai Y, Akaike H, Ouchi K, Hayashi T, Kurihara T, et al. Macrolide-resistant Mycoplasma pneumoniae in adolescents with community-acquired pneumonia. BMC Infect Dis. 2012;12:126.
Article
CAS
PubMed
PubMed Central
Google Scholar
Takei T, Morozumi M, Ozaki H, Fujita H, Ubukata K, Kobayashi I, et al. Clinical features of Mycoplasma pneumoniae infections in the 2010 epidemic season: report of two cases with unusual presentations. Pediatr Neonatol. 2013;54:402–5.
Article
PubMed
Google Scholar
Liu Y, Ye X, Zhang H, Xu X, Li W, Zhu D, et al. Antimicrobial susceptibility of Mycoplasma pneumoniae isolates and molecular analysis of macrolide-resistant strains from shanghai, China. Antimicrob Agents Chemother. 2009;53:2160–2.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zhao F, Liu G, Wu J, Cao B, Tao X, He L, et al. Surveillance of macrolide-resistant Mycoplasma pneumoniae in Beijing, China, from 2008 to 2012. Antimicrob Agents Chemother. 2013;57:1521–3.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ho PL, Law PY, Chan BW, Wong CW, To KK, Chiu SS, et al. Emergence of macrolide-resistant Mycoplasma pneumoniae in Hong Kong is linked to increasing macrolide resistance in multilocus variable-number tandem-repeat analysis type 4-5-7-2. J Clin Microbiol. 2015;53:3560–4.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ferwerda A, Moll HA. Groot Rd. respiratory tract infections by Mycoplasma peumoniae in childrne: a revies of diagnostic and therapeutic measures. Eur J Pediatr. 2001;160:483–91.
Article
CAS
PubMed
Google Scholar
Gardiner SJ, Gavranich JB, Chang AB. Antibiotics for community-acquired lower respiratory tract infections secondary to Mycoplasma pneumoniae in children. Cochrane Database Syst Rev. 2015;1:CD004875.
PubMed
Google Scholar
Okazaki N, Narita M, Yamada S, Izumikawa K, Umetsu M, Kenri T, et al. Characteristics of macrolide-resistant Mycoplasma pneumoniae strains isolated from patients and induced with erythromycin in vitro. Microbiol Immunol. 2001;45:617–20.
Article
CAS
PubMed
Google Scholar
Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing-twenty-first information Spplement: approved standard M100-S21. Wayne, PA: CLSI; 2011.
Google Scholar
Morozumi M, Ubukata K, Takahashi T. Macrolide-resistant Mycoplasma pneumoniae: characteristics of isolates and clinical aspects of community-acquired pneumonia. J Infect Chemother. 2010;16:78–86.
Article
PubMed
Google Scholar
Liu Y, Ye X, Zhang H, Xu X, Li W, Zhu D, et al. Characterization of macrolide resistance in Mycoplasma pneumoniae isolated from children in shanghai. China Diagn Microbiol Infect Dis. 2010;67:355–8.
Article
CAS
PubMed
Google Scholar
Xin D, Mi Z, Han X, Qin L, Li J, Wei T, et al. Molecular mechanisms of macrolide resistance in clinical isolates of Mycoplasma pneumoniae from China. Antimicrob Agents Chemother. 2009;53:2158–9.
Article
CAS
PubMed
PubMed Central
Google Scholar
Averbuch D, Hidalgo-Grass C, Moses AE, Engelhard D, Nir-Paz R. Macrolide resistance in Mycoplasma pneumoniae, Israel, 2010. Emerg Infect Dis. 2011;17:1079–82.
Article
PubMed
PubMed Central
Google Scholar
Chironna M, Sallustio A, Esposito S, Perulli M, Chinellato I, Di Bari C, et al. Emergence of macrolide-resistant strains during an outbreak of Mycoplasma pneumoniae infections in children. J Antimicrob Chemother. 2011;66:734–7.
Article
CAS
PubMed
Google Scholar
Wolff BJ, Thacker WL, Schwartz SB, Winchell JM. Detection of macrolide resistance in Mycoplasma pneumoniae by real-time PCR and high-resolution melt analysis. Antimicrob Agents Chemother. 2008;52:3542–9.
Article
CAS
PubMed
PubMed Central
Google Scholar
Morozumi M, Hasegawa K, Kobayashi R, Inoue N, Iwata S, Kuroki H, et al. Emergence of macrolide-resistant Mycoplasma pneumoniae with a 23S rRNA gene mutation. Antimicrob Agents Chemother. 2005;49:2302–6.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bebear CM, Pereyre S. Mechanisms of drug resistance in Mycoplasma pneumoniae. Curr Drug Targets Infect Disord. 2005;5:263–71.
Article
CAS
PubMed
Google Scholar
Morozumi M, Iwata S, Hasegawa K, Chiba N, Takayanagi R, Matsubara K, et al. Increased macrolide resistance of Mycoplasma pneumoniae in pediatric patients with community-acquired pneumonia. Antimicrob Agents Chemother. 2008;52:348–50.
Article
CAS
PubMed
Google Scholar
Kinston JR, Chanock RM, Mufson MA, Hellman LP, James WD, Fox HH, et al. Eaton agent pneumonia. JAMA. 1961;176:118–23.
Article
Google Scholar
Critchley IA, Jones ME, Heinze PD, Hubbard D, Engler HD, Evangelista AT, et al. In vitro activity of levofloxacin against contemporary clinical isolates of Legionella pneumophila, Mycoplasma pneumoniae and Chlamydia pneumoniae from North America and Europe. Clin Microbiol Infect. 2002;8:214–21.
Article
CAS
PubMed
Google Scholar
Shah SS, Test M, Sheffler-Collins S, Weiss AK, Hall M. Macrolide therapy and outcomes in a multicenter cohort of children hospitalized with Mycoplasma pneumoniae pneumonia. J Hosp Med. 2012;7:311–7.
Article
PubMed
Google Scholar
Biondi E, McCulloh R, Alverson B, Klein A, Dixon A, Ralston S. Treatment of mycoplasma pneumonia: a systematic review. Pediatrics. 2014;133:1081–90.
Article
PubMed
Google Scholar
Kawai Y, Miyashita N, Yamaguchi T, Saitoh A, Kondoh E, Fujimoto H, et al. Clinical efficacy of macrolide antibiotics against genetically determined macrolide-resistant Mycoplasma pneumoniae pneumonia in paediatric patients. Respirology. 2012;17:354–62.
Article
PubMed
Google Scholar
Matsubara K, Morozumi M, Okada T, Matsushima T, Komiyama O, Shoji M, et al. A comparative clinical study of macrolide-sensitive and macrolide-resistant Mycoplasma pneumoniae infections in pediatric patients. J Infect Chemother. 2009;15:380–3.
Article
PubMed
Google Scholar
Suzuki S, Yamazaki T, Narita M, Okazaki N, Suzuki I, Andoh T, et al. Clinical evaluation of macrolide-resistant Mycoplasma pneumoniae. Antimicrob Agents Chemother. 2006;50:709–12.
Article
CAS
PubMed
PubMed Central
Google Scholar
Okada T, Morozumi M, Tajima T, Hasegawa M, Sakata H, Ohnari S, et al. Rapid effectiveness of minocycline or doxycycline against macrolide-resistant Mycoplasma pneumoniae infection in a 2011 outbreak among Japanese children. Clin Infect Dis. 2012;55:1642–9.
Article
CAS
PubMed
Google Scholar
Spuesens EB, Meyer Sauteur PM, Vink C, van Rossum AM. Mycoplasma pneumoniae infections-does treatment help? J Inf Secur. 2014;69:S42–6.
Google Scholar
Othman N, Isaacs D, Daley AJ, Kesson AM. Mycoplasma pneumoniae infection in a clinical setting. Pediatr Int. 2008;50:662–6.
Article
PubMed
Google Scholar